Information found nowhere else Biomarkers: Technological and Commercial Outlook 2013-2023 gives independent analysis. There you receive business intelligence found only in our work, finding where money lies.
With that report you are less likely to fall behind in knowledge or miss sales opportunity. See how you could benefit your research, analysis, and decisions. Also find how you can save time and get recognition for insight.
Biomarkers for healthcare - assess potentials now, seeing what you can gain
Our new report is for everyone investigating biomarker technologies. There discover revenue forecasts to 2023 at overall world market, submarket, and national level. Find discussions too. Avoid missing out then - please order the report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Table of Contents 1. Executive Summary 1.1 Biomarkers: World Market Overview
1.2 Chapter Breakdown
1.3 Research and Analysis Methods
1.4 Market Definition, 2013
2. An Introduction to Biomarkers
2.1 Definition of a Biomarker2.1.1 A Brief History of Biomarkers2.1.2 The Importance of Biomarkers2.2 Biomarker Discovery and Validation2.3 Uses of Biomarkers2.3.1 Assessing Drug Efficacy2.3.2 Assessing Drug Safety2.3.3 Companion Diagnostics18.104.22.168 CLIA vs. FDA Approval2.3.4 Therapeutic Importance of Biomarkers2.3.5 Imaging Biomarkers22.214.171.124 Imaging Biomarkers in Clinical Trials2.4 Biomarkers and Personalised Medicine2.5 Biomarker Discovery2.5.1 Genomics126.96.36.199 Pharmacogenomics2.5.2 Proteomics2.5.3 Metabolomics
3. The World Biomarkers Market, 2013-2023
3.1 The World Biomarkers Market, 2012
3.1.1 The World Biomarkers Market by Sector, 2012
3.1.2 The World Biomarkers Market by Discipline, 2012
3.2 The W
Copyright©2012 PR Newswire.
All rights reserved